@ARTICLE{
author={Robak Tadeusz|,Windyga Jerzy|,Trelinski Jacek|,Prondzinski Mario von Depka|,Giagounidis Aristoteles|,Doyen Chantal|,Janssens Ann|,Teresa Alvarez-Roman Maria|,Jarque Isidro|,Loscertales Javier|,Perez-Rus Gloria|,Hellmann Andrzej|,Jedrzejczak Wieslaw Wiktor|,Kuliczkowski Kazimierz|,Golubovic Lana M|,Celeketic Dusica C|,Cucuianu Andrei|,Gheorghita Emanuil|,Lazaroiu Mihaela|,Shpilberg Ofer|,Attias Dina|,Karyagina Elena|,Svetlana Kalinina|,Vilchevska Kateryna|,Cooper Nichola|,Talks Kate|,Prabhu Mukhyaprana|,Sripada Prasad|,Bharadwaj TPR|,Naested Henrik|,Skartved Niels JO|,Frandsen Torben P|,Flensburg Mimi F|,S-Andersen Peter|,Petersen Jorgen B|},
year={2012},
title={Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia},
journal={BLOOD},
volume={120},
number={18},
pages={3670-3676},
document_type={Article},
}